New microtubule polymerization inhibitors comprising a nitrooxymethylphenyl group
New microtubule polymerization inhibitors comprising a nitrooxymethylphenyl group
复制标题
包含硝基氧基甲基苯基的新型微管聚合抑制剂
DOI:
10.1016/j.bmc.2011.05.031
复制
发表时间:
2011
期刊:
影响因子:
--
通讯作者:
他5名
中科院分区:
文献类型:
--
作者:
Y.Kawaratani;T.Harada;Y.Hirata;Y.Nagaoka;S.Uesato;他5名
We have designed cancer antiproliferative compounds, starting from aniline or phenol derivative, which comprise one or two nitrooxymethylphenyl groups as do the hybrid drugs NCX4040 and NCX530. Compound2awithp-nitrooxymethylbenzoyl-oxy and -amino groups as well as8awith ap-nitrooxymethylbenzoylamino group showed more promising effects than NCX4040 against human colon and breast cancer cells. Since2aand8a, but not NCX4040, arrested human colon carcinoma HCT116 cells in the M phase, the former two compounds may inhibit cell growth differently from NCX4040. Merged images of immunofluorescence-stained α-tubulin and Hoechst-stained nuclei in human fibrosarcoma HT1080 cells showed that2aand8adisrupted microtubule formation just as did vincristine, the tubulin polymerization inhibitor. In experiments in vivo, the intraperitoneal administration of8aat 80 mg/kg/day reduced the growth of HCT116 xenografts in nude mice toT/C55%.